Inari Medical is a medical device company. Co.'s product offerings consist of two minimally-invasive, catheter-based mechanical thrombectomy systems for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, deep vein thrombosis, or DVT, and pulmonary embolism. Co.'s solutions include: ClotTriever System, which is a mechanical thrombectomy system designed to core, capture and remove clots from vessels and is used to treat DVT; FlowTriever System, which is a bore catheter-based aspiration and mechanical thrombectomy system; and ancillary products, which include FlowSaver, FlowStasis, and FlowTriever 2. The NARI YTD return is shown above.
The YTD Return on the NARI YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether NARI YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NARI YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|